Table 2.
Summary table of the ANOVA results applied to protocol 1 data
| Trial type | TPJ group |
hMT/V5 + group |
||||
|---|---|---|---|---|---|---|
| ΔTE ± SEM (ms) | TMS F(1,20) | TMS × MD F(3,20) | ΔTE ± SEM (ms) | TMS F(1,20) | TMS × MD F(3,20) | |
| Between-group design | ||||||
| −g | 2.6 (7.1) | 0.11 | 0.12 | −16.3 (7.2) | 4.67* | 0.3 |
| g | −15.3 (4.1) | 12.7** | 0.36 | −22.7 (5.6) | 19.01** | 2.14 |
| RT | −4.1 (7.7) | 0.25 | 0.1 | −2.0 (6.6) | 0.13 | 2.92 |
| Within-group design | ||||||
| −g | −3.7 (7.0) | 0.27 | 0.49 | −18.3 (8.1) | 4.58* | 0.28 |
| g | −27.5 (2.9) | 80.0** | 0.44 | −25.3 (5.2) | 23.6** | 1.0 |
| RT | −9.6 (5.9) | 2.8 | 1.4 | −7.4 (5.9) | 1.7 | 1.6 |
Along with the mean ΔTEs (± SEM) computed over all trials and target motion duration (MD), we report the F ratios of the main effect of TMS and its interaction with the MD (TMS × MD), testing the overall effect of TMS on the response timing and its dependence on the MD, respectively. Statistically significant effects are indicated in bold. *p < 0.05; **p < 0.001.